The Editor's Corner


The impact of intraoperative residual mild regurgitation after repair of degenerative mitral regurgitation.

Bartlomiej Imielski, MD, S. Chris Malaisrie, MD, Duc Thinh Pham, MD, Jane Kruse, RN, BSN, Adin-Cristian Andrei, PhD, Menghan Liu, MS, James L. Cox, MD, and Patrick M. McCarthy, MD
Submitted by: José Daniel Espinoza Hernández, MD. FACS, FCCP

  Wed, 04/28/2021

Mitral valve

Initial Invasive or Conservative Strategy for Stable Coronary Disease. N Engl J Med (2020)

D.J. Maron, J.S. Hochman, H.R. Reynolds, S. Bangalore, S.M. O’Brien, W.E. Boden, B.R. Chaitman, R. Senior, the ISCHEMIA Research Group
Submitted by: Daniel Navia, MD

  Fri, 04/16/2021

Coronary disease / CABG

The 2020 American College of Cardiology/ American Heart Association (ACC/AHA) Guideline for the Management of Patients with Valvular Heart Disease. Should the World Jump In?. Braz J Cardiovasc Surg (2021)

Walter J Gomes, MD, PhD; Rui M S Almeida, MD, PhD; Orlando Petrucci, MD, PhD; Manuel J. Antunes, MD, PhD; Luciano C. Albuquerque, MD, PhD
Submitted by: Walter J Gomes, MD PhD

  Fri, 04/16/2021

Aortic valve, Mitral valve

The Impact of Left Atrial Reduction during Surgical Ablation of Atrial Fibrillation

Choi W, Kim HJ, Park SY, Kim JB, Jung S-H, Lee JW, . Semin Thorac Cardiovasc Surg (2021)
Submitted by: Ovidio A. García-Villarreal, MD

  Wed, 04/14/2021

Atrial Fibrillation